Department of Radiation Oncology

Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells (2022) Stoll E, Hader M, Rückert M, Weissmann T, Lettmaier S, Putz F, Hecht M, et al. Journal article Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines (2022) Schatz J, Ladinig A, Fietkau R, Putz F, Gaipl U, Frey B, Derer A Journal article Effect of Citrate- and Gold-Stabilized Superparamagnetic Iron Oxide Nanoparticles on Head and Neck Tumor Cell Lines during Combination Therapy with Ionizing Radiation (2022) Schreiber C, Franzen T, Hildebrand L, Stein R, Friedrich B, Tietze R, Fietkau R, Distel L Journal article Brachytherapy training survey among radiation oncology residents in Europe (2022) Sturdza AE, Stephanides M, Jurgenliemk-Schulz I, Eriksen JG, Benstead K, Hoskin P, Vlad S, et al. Journal article Orofacial clefts lead to increased pro-inflammatory cytokine levels on neonatal oral mucosa (2022) Seidel CL, Percivalle E, Tschaftari M, Weider M, Strobel K, Willershausen I, Unertl C, et al. Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2022) Jost T, Faulhaber EM, Symank JA, Scheper J, Bürkel F, Fietkau R, Hecht M, Distel L Conference contribution, Abstract of a poster The Impact of Irradiation and Lipotransfer on Healthy Mammary Cells after Breast-Conserving Surgery (2022) Kutz CS, Jost T, Distel L, Kengelbach-Weigand A, Hauck T, Horch RE Conference contribution Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2022) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller SK, Traxdorf M, et al. Conference contribution Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells (2022) Poczta A, Krzeczynski P, Ionov M, Rogalska A, Gaipl U, Marczak A, Lubgan D Journal article